Is Mitragynine Pseudoindoxyl Legal in Maryland? (2026)

Federal

Pseudoindoxyl -- federally Schedule I (DEA temporary order, drug code 9672, eff. 2026-08-26) (effective 2026-08-26). State-law reading underneath: Restricted.

Rule type

permanent

Tier

concentration cap

Limit

2 percent alkaloid composition (percentage alkaloid fraction)

Effective

2024-10-01

Effectively prohibitive

yes, in practice

Controlling language, verbatim

A RETAILER MAY NOT PREPARE, DISTRIBUTE, SELL, OR EXPOSE FOR SALE ANY OF THE FOLLOWING: ... (III) A KRATOM PRODUCT CONTAINING A LEVEL OF 7-HYDROXYMITRAGYNINE IN THE ALKALOID FRACTION THAT IS GREATER THAN 2% OF THE ALKALOID COMPOSITION OF THE PRODUCT; (IV) A KRATOM PRODUCT CONTAINING A SYNTHETIC ALKALOID ...

Source of excerpt

Citations

No citation on file for this row yet.

Change history

• 2026-09-23Status changed from illegal to restricted.
• 2026-09-23Status changed from restricted to illegal.

Where Mitragynine Pseudoindoxyl stands across the country

Among Maryland's 5 neighbors, District of Columbia, Delaware, Pennsylvania, Virginia and West Virginia are illegal, the same posture as Maryland.

Open the interactive map · Every compound in Maryland

Federal posture

Federally scheduled or prohibited. Pseudoindoxyl -- federally Schedule I (DEA temporary order, drug code 9672, eff. 2026-08-26) Federal detail

Pending deadlines

• 2026-08-01 · Federal · DEA temporary Schedule I order for mitragynine pseudoindoxyl, MGM-15, MGM-16 - effective on Federal Register publication (DEA NOI 2026-07-01)
• 2026-08-05 · Federal · DEA temporary Schedule I - mitragynine pseudoindoxyl, MGM-15, MGM-16 (DEA-1644 / FR 2026-17429)
  Second DEA Notice of Intent filed with the Federal Register on 7/1/2026 (companion to the 7-OH NOI, DEA-1570), placing three 7-OH-RELATED substances — mitragynine pseudoindoxyl (MP), MGM-15, and MGM-16 — into Schedule I under 21 U.S.C. 811(h). HHS confirmed these have no accepted medical use and a high potential for abuse. Same procedural clock as the 7-OH NOI: 30-day notice period, temporary order cannot issue before ~2026-08-05, effective on Federal Register publication of the order, 2-year duration (+1 yr possible). Unlike the 7-OH NOI there is NO concentration threshold here — these named substances are controlled outright. Confirm the exact companion docket number when the Federal Register posts on 7/6/2026.
• 2026-11-13 · Federal · DEA to replace pseudoindoxyl Schedule I order with a threshold order (re-notice) (DEA-1570 / FR 2026-20943)
  On or after Nov 13, 2026 DEA intends to withdraw the Aug 26 order (FR 2026-17429) and place pseudoindoxyl in Schedule I only above a threshold: more than 1 mg/g or 1 mg/mL alone or combined with 7-OH, or mitragynine under 100 times the pseudoindoxyl or combined amount. Until then it stays Schedule I at any amount. MGM-15 and MGM-16 stay Schedule I unchanged (FR 2026-20942).

Verbatim law on file for Maryland

1 instrument on file for this compound's framework in Maryland; 0 of 0 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

21-2D-01. (B) "Kratom product" means a food product or dietary ingredient product marketed for human consumption containing any part of the leaf of the plant Mitragyna speciosa. (C) "Retailer" means a person that sells/prepares/maintains kratom products (incl. manufacturer, wholesaler, store, convenience store, gas station, etc.).
21-2D-02. (A) A retailer ... shall disclose on the product label the factual basis on which the representation [as kratom] is made ... (B)(1) A retailer may not prepare, distribute, sell, or expose for sale: (I) a kratom product adulterated with a dangerous substance other than kratom; (II) contaminated ...; (III) A kratom product containing a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than 2% of the alkaloid composition of the product; (IV) A kratom product containing a synthetic alkaloid, including synthetic mitragynine, synthetic 7-hydroxymitragynine, or any other synthetically derived compound of the kratom plant; or (V) a product containing kratom that does not include on its package or label the amount of mitragynine and 7-hydroxymitragynine ... (C) A retailer may not distribute, sell, or expose for sale a kratom product to an individual under the age of 21 years. (E) civil penalty up to $1,000/$2,000. (F) misdemeanor fine up to $5,000, up to 90 days, or both.

Related

Mitragynine Pseudoindoxyl in neighboring states

• Mitragynine Pseudoindoxyl in District of Columbia Illegal
• Mitragynine Pseudoindoxyl in Delaware Illegal
• Mitragynine Pseudoindoxyl in Pennsylvania Illegal
• Mitragynine Pseudoindoxyl in Virginia Illegal
• Mitragynine Pseudoindoxyl in West Virginia Illegal

Mitragynine Pseudoindoxyl in other states

Same framework in Maryland

• 7-OH (7-Hydroxymitragynine) in Maryland Restricted
• Kratom (Whole Leaf / Mitragynine) in Maryland Restricted
• Speciociliatine in Maryland Restricted

Other compounds in Maryland

Cite this page